Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Zymeworks Inc. (ZYME)

24   0.12 (0.5%) 07-16 16:02
Open: 23.95 Pre. Close: 23.88
High: 24.39 Low: 23.32
Volume: 296,065 Market Cap: 948M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 24.489 - 24.642 24.642 - 24.75
Low: 23.181 - 23.37 23.37 - 23.503
Close: 23.631 - 23.909 23.909 - 24.104

Technical analysis

as of: 2019-07-16 3:25:13 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 29.78     One year: 34.79
Support: Support1: 20.62    Support2: 17.60
Resistance: Resistance1: 25.50    Resistance2: 29.78
Pivot: 23.44
Moving Average: MA(5): 24.01     MA(20): 22.68
MA(100): 18.20     MA(250): 15.71
MACD: MACD(12,26): 1.15     Signal(9): 1.17
Stochastic oscillator: %K(14,3): 67.06     %D(3): 71.81
RSI: RSI(14): 65.95
52-week: High: 25.50  Low: 10.72  Change(%): 63.6
Average Vol(K): 3-Month: 29225  10-Days: 34537

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ZYME has closed below upper band by 30.5%. Bollinger Bands are 15.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 28 Jun 2019 05:10:52 Z
Red Hot Stocks Ahead of G20 Summit

Wed, 26 Jun 2019 12:09:36 Z
Will Zymeworks Continue to Surge Higher?

Wed, 07 Nov 2018 02:54:58 Z
Zymeworks Inc. (ZYME) Reports Q3 Loss, Tops Revenue Estimates

Fri, 28 Apr 2017 14:28:17 Z
Zymeworks prices IPO at $13, the low end of the range

Mon, 17 Apr 2017 15:55:53 Z
Cancer biotech Zymeworks sets terms for $65 million IPO

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 32.06
Shares Float (M) 25.15
% Held by Insiders 17.60
% Held by Institutions 40.19
Shares Short (K) 385
Shares Short P. Month (K)

Stock Financials

EPS -0.950
EPS Est. Current Year -2.980
EPS Est. Next Year -2.540
EPS Est. Next Quarter -0.670
Forward EPS -2.309
Book Value (p.s.) 5.300
PEG Ratio
Profit Margin -44.67
Operating Margin -42.60
Return on Assets (ttm) -9.8
Return on Equity (ttm) -21.9
Qtrly Rev. Growth 29712.5
Gross Profit (p.s.) -0.114
Sales Per Share
EBITDA (p.s.) -0.790
Qtrly Earnings Growth
Operating Cash Flow (M) 20.45
Levered Free Cash Flow (M) 0.77

Stock Valuations

P/E -25.37
P/E Growth Ratio 0.01
P/BV 4.55
P/S 366182944.00
P/CF 37.78

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.